| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.42B | 36.77B | 32.26B | 26.08B | 30.12B | 26.66B |
| Gross Profit | 3.02B | 3.91B | 2.98B | 1.72B | 3.47B | 2.22B |
| EBITDA | 1.08B | 1.97B | 1.13B | 357.00M | 2.01B | 864.00M |
| Net Income | 555.00M | 964.00M | 611.00M | 75.00M | 1.32B | 355.00M |
Balance Sheet | ||||||
| Total Assets | 25.76B | 25.35B | 27.49B | 26.33B | 26.82B | 25.88B |
| Cash, Cash Equivalents and Short-Term Investments | 14.78B | 8.72B | 14.10B | 13.94B | 12.39B | 10.11B |
| Total Debt | 1.30B | 2.23B | 1.33B | 1.35B | 1.30B | 1.59B |
| Total Liabilities | 11.38B | 14.00B | 11.96B | 11.08B | 11.24B | 11.31B |
| Stockholders Equity | 14.38B | 11.35B | 15.52B | 15.24B | 15.57B | 14.55B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -826.00M | 579.00M | 1.97B | 2.72B | 754.00M |
| Operating Cash Flow | 0.00 | -701.00M | 900.00M | 2.01B | 2.91B | 1.32B |
| Investing Cash Flow | 0.00 | -399.00M | -362.00M | -97.00M | -21.00M | -584.00M |
| Financing Cash Flow | 0.00 | -4.28B | -371.00M | -367.00M | -601.00M | -230.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥15.88B | 8.50 | ― | 2.87% | 0.52% | 10.43% | |
70 Outperform | ¥11.40B | 4.04 | ― | 1.60% | 1.17% | 65.87% | |
68 Neutral | ¥11.74B | 5.65 | ― | 1.01% | -13.50% | 22.11% | |
65 Neutral | ¥15.19B | 7.78 | ― | 3.68% | -9.66% | 22.05% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥12.24B | 13.42 | ― | 5.36% | 13.96% | 85.01% | |
62 Neutral | ¥18.22B | 46.87 | ― | 2.54% | -3.27% | 134.48% |